Labau JIR

Maastricht University Medical Centre

1
Publications in this database

PubMed name variants: Labau JIR. Uses the same surname-and-first-initial grouping as the researcher table; matches are not verified identities.

6
Career-wide h-index · OpenAlex
(179 citations, 7 total works)

Career-wide Research Topics · OpenAlex

Topic counts cover the OpenAlex author’s full publication record, across all conditions.

Pain Mechanisms and Treatments (6)Ion channel regulation and function (6)Ion Channels and Receptors (6)Cardiac electrophysiology and arrhythmias (1)Pluripotent Stem Cells Research (1)

Erythromelalgia Publications

Stem cell-derived sensory neurons modelling inherited erythromelalgia: normalization of excitability.

Alsaloum M, Labau JIR, Liu S, Effraim PR, Waxman SG
Brain : a journal of neurology •

Effective treatment of pain remains an unmet healthcare need that requires new and effective therapeutic approaches. NaV1.7 has been genetically and functionally validated as a mediator of pain. Preclinical studies of NaV1.7-selective blockers have shown limited success and translation to clinical studies has been limited. The degree of NaV1.7 channel blockade necessary to attenuate neuronal excitability and ameliorate pain is an unanswered question important for drug discovery. Here, we utilize dynamic clamp electrophysiology and induced pluripotent stem cell-derived sensory neurons (iPSC-SNs) to answer this question for inherited erythromelalgia, a pain disorder caused by gain-of-function mutations in Nav1.7. We show that dynamic clamp can produce hyperexcitability in iPSC-SNs associated with two different inherited erythromelalgia mutations, NaV1.7-S241T and NaV1.7-I848T. We further show that blockade of approximately 50% of NaV1.7 currents can reverse neuronal hyperexcitability to baseline levels.